These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36755044)
21. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419 [TBL] [Abstract][Full Text] [Related]
22. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis. McPhail GL; Clancy JP Drugs Today (Barc); 2013 Apr; 49(4):253-60. PubMed ID: 23616952 [TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Becq F Drugs; 2010 Feb; 70(3):241-59. PubMed ID: 20166764 [TBL] [Abstract][Full Text] [Related]
24. Small-molecule drugs for cystic fibrosis: Where are we now? Laselva O; Guerra L; Castellani S; Favia M; Di Gioia S; Conese M Pulm Pharmacol Ther; 2022 Feb; 72():102098. PubMed ID: 34793977 [TBL] [Abstract][Full Text] [Related]
25. Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis. O'Reilly R; Elphick HE Drug Des Devel Ther; 2013; 7():929-37. PubMed ID: 24039402 [TBL] [Abstract][Full Text] [Related]
26. Advances in the diagnosis and treatment of cystic fibrosis. Martiniano SL; Hoppe JE; Sagel SD; Zemanick ET Adv Pediatr; 2014 Aug; 61(1):225-43. PubMed ID: 25037130 [TBL] [Abstract][Full Text] [Related]
27. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review. Yang H; Ma T Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311 [TBL] [Abstract][Full Text] [Related]
28. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein]. Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675 [TBL] [Abstract][Full Text] [Related]
29. New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator. Ong T; Ramsey BW Pediatr Clin North Am; 2016 Aug; 63(4):751-64. PubMed ID: 27469186 [TBL] [Abstract][Full Text] [Related]
30. An Update on CFTR Modulators as New Therapies for Cystic Fibrosis. King JA; Nichols AL; Bentley S; Carr SB; Davies JC Paediatr Drugs; 2022 Jul; 24(4):321-333. PubMed ID: 35570261 [TBL] [Abstract][Full Text] [Related]
31. Entering the era of highly effective modulator therapies. Dave K; Dobra R; Scott S; Saunders C; Matthews J; Simmonds NJ; Davies JC Pediatr Pulmonol; 2021 Feb; 56 Suppl 1():S79-S89. PubMed ID: 33434412 [TBL] [Abstract][Full Text] [Related]